The nation of Zimbabwe has rejected a substantial American health deal worth 367 million US dollars (272 million pounds) spanning five years due to the United States' demand for sensitive biological samples.
This move came to light following a official document dated December was leaked, indicating that Head of State Emmerson Mnangagwa deemed the deal was "skewed".
An official representative later clarified that the US was demanding access to genetic material for scientific study and profit while was unwilling to share the benefits from any future treatments.
"We must now begin the difficult and regrettable process of scaling back our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the US had provided more than $1.9bn in health funding to Zimbabwe over the last two decades.
A medical body in Zimbabwe has called for more dialogue to secure a deal suitable to both sides so the country's critical HIV programme can continue.
Wider Context
This rejection follows a comparable situation in neighbouring Kenya, where a high court suspended a similar health funding agreement following legal challenges were raised about the security of Kenyans' medical information.
Since resuming the presidency recently, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).
The agency had managed aid for the American government, but Trump stated its spending was "inefficient" and his administration was seeking government-to-government deals to enhance openness and accountability.
Based on statements, 16 African countries have so far agreed to these new health pacts, representing more than $18.3bn in committed funds.
Specifics of the Rejected Deal
The money for Zimbabwe would have supported "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this collaboration might have yielded extraordinary advantages for Zimbabwean communities, particularly the 1.2 million men, women and children currently on HIV treatment via American-funded programmes," Tremont added.
However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".
"Zimbabwe was being asked to surrender its genetic material and health information for a long time, with no equivalent guarantee of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could result from that shared data," Mangwana explained.
"Put simply, our country would provide the basic resources for scientific discovery with no certainty that the end products would be accessible to our population should a new disease outbreak emerge."
National Interest and Global Health
He also said that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were undermining frameworks previously established via the global organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to manage future pandemics.
"This mechanism is intended to ensure that when a nation contributes its samples, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the funds to develop them."
These objections regarding the US deal "should not be misconstrued as anti-American sentiment," he added.
"We encourage ongoing discussions with our American counterparts on how future co-operation might be designed in a manner that honours the independence and dignity of each country."
Medical Community Reaction
Medical experts stated it recognised the government's concerns, but recommended that negotiations should continue given that much of the nation's Aids initiatives relied on foreign aid.
"In cases where technical issues arise, including those involving data governance or agreement terms, these can often be addressed via detailed discussion and negotiated safeguards," the group said.
The halted deal emphasises the ongoing challenges between receiving crucial international aid and safeguarding national sovereignty in an ever more interconnected world.